221 related articles for article (PubMed ID: 11101862)
1. NKT cells and tumor immunity--a double-edged sword.
Smyth MJ; Godfrey DI
Nat Immunol; 2000 Dec; 1(6):459-60. PubMed ID: 11101862
[No Abstract] [Full Text] [Related]
2. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
3. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
4. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.
Azuma T; Takahashi T; Kunisato A; Kitamura T; Hirai H
Cancer Res; 2003 Aug; 63(15):4516-20. PubMed ID: 12907625
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
[TBL] [Abstract][Full Text] [Related]
6. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
Stenström M; Sköld M; Andersson A; Cardell SL
Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
[TBL] [Abstract][Full Text] [Related]
7. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.
Osada T; Morse MA; Lyerly HK; Clay TM
Int Immunol; 2005 Sep; 17(9):1143-55. PubMed ID: 16027139
[TBL] [Abstract][Full Text] [Related]
9. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
10. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double-positive CD4+ CD8+ cells and B220+ T cells, in mice.
Ishimoto Y; Tomiyama-Miyaji C; Watanabe H; Yokoyama H; Ebe K; Tsubata S; Aoyagi Y; Abo T
Immunology; 2004 Nov; 113(3):371-7. PubMed ID: 15500624
[TBL] [Abstract][Full Text] [Related]
12. Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.
Miyazaki Y; Iwabuchi K; Iwata D; Miyazaki A; Kon Y; Niino M; Kikuchi S; Yanagawa Y; Kaer LV; Sasaki H; Onoé K
Scand J Immunol; 2008 Mar; 67(3):230-7. PubMed ID: 18226013
[TBL] [Abstract][Full Text] [Related]
13. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
14. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.
Agrati C; Nisii C; Oliva A; D'Offizi G; Montesano C; Pucillo LP; Poccia F
Arch Immunol Ther Exp (Warsz); 2002; 50(5):307-16. PubMed ID: 12455864
[TBL] [Abstract][Full Text] [Related]
16. Immune suppression and skin cancer development: regulation by NKT cells.
Moodycliffe AM; Nghiem D; Clydesdale G; Ullrich SE
Nat Immunol; 2000 Dec; 1(6):521-5. PubMed ID: 11101875
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity.
Goust JM
Immunol Ser; 1990; 50():195-215. PubMed ID: 2151118
[No Abstract] [Full Text] [Related]
19. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.
Liu Y; Bi X; Xu S; Xiang J
Cancer Res; 2005 Jun; 65(11):4955-62. PubMed ID: 15930318
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.
Stewart TJ; Smyth MJ; Fernando GJ; Frazer IH; Leggatt GR
Cancer Res; 2003 Jun; 63(12):3058-60. PubMed ID: 12810627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
